Hillan Kenneth J. is Chief Therapeutics Officer of 23andMe Holding Co - Ordinary Shares.
Person profile
Roles
23andMe Holding Co - Ordinary Shares
Chief Therapeutics Officer
Zymeworks
Director
Sangamo Therapeutics
Director
Address
South San Francisco, California
Employees
Former names
Hillan Kenneth
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Zymeworks Inc.
8 Dec 23
4
23andMe Holding Co.
7 Jun 23
4
SANGAMO THERAPEUTICS, INC
5 Jun 23
4
23andMe Holding Co.
23 May 23
4
23andMe Holding Co.
22 Feb 23
4
Zymeworks Inc.
23 Dec 22
4
23andMe Holding Co.
22 Nov 22
4
23andMe Holding Co.
25 Aug 22
4
23andMe Holding Co.
22 Aug 22
4
23andMe Holding Co.
2 Jun 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
7 Dec 23 | ZYME Zymeworks | Stock Option Common Stock | Grant | Acquire A | No | No | 9.55 | 37,000 | 353.35 k | 37,000 |
5 Jun 23 | ME 23andMe Holding Co - Ordinary Shares | Class A Common Stock | Payment of exercise | Dispose F | No | No | 2.08 | 15,347 | 31.92 k | 221,876 |
5 Jun 23 | ME 23andMe Holding Co - Ordinary Shares | Class A Common Stock | Grant | Acquire A | No | No | 0 | 44,381 | 0.00 | 237,223 |
1 Jun 23 | SGMO Sangamo Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 13,900 | 0.00 | 49,600 |
1 Jun 23 | SGMO Sangamo Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.11 | 27,750 | 30.80 k | 27,750 |
20 May 23 | ME 23andMe Holding Co - Ordinary Shares | Class A Common Stock | Payment of exercise | Dispose F | No | No | 1.94 | 4,628 | 8.98 k | 192,842 |
20 Feb 23 | ME 23andMe Holding Co - Ordinary Shares | Class A Common Stock | Payment of exercise | Dispose F | No | No | 2.87 | 5,457 | 15.66 k | 191,705 |